|Videos|April 20, 2021

Automated Container Closure Integrity (CCI) Inspection System for Parenteral Products

Author(s)PTI

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe

Related Content

Dr. Laura Daley on how success in emerging biopharma depends not only on speed, but also on making confident, data-informed decisions early in development while managing increasing molecular complexity.

What It Takes to Support Emerging Biopharma Programs Through Rapid Candidate Identification

ByLaura Daley, PhD, Catalent Pharma Solutions,Jeanne Linke Northrop, BioPharm International

June 17th 2026

Sponsored

Nuno Fontes, man in black suit jacket and white button down standing in front of blue and white background for interview

Expanding CDMO Capabilities in Drug Manufacturing

ByNuno Fontes, SVP, Head of Global CMC,WuXi Biologics

May 14th 2026

Sponsored

How Biologic Developers are Using Optimized Platforms and Operations to Reach First-in-Human Trials

ByEmily Schirmer, Catalent,Jeanne Linke Northrop, BioPharm International

May 13th 2026

Sponsored

Choosing the Right CDMO for Long-Term Stability

ByDr. Patrick Meyer, Global Head of Business Development,Rentschler Biopharma

Published: May 4th 2026 | Updated: May 4th 2026

Sponsored

Reducing Timelines and Eliminating the White Space in Complex Biologic & Bioconjugate Development

ByCampbell Bunce,Abzena

Published: April 23rd 2026 | Updated: January 14th 2026

Sponsored